rs187714514
Positions:
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BS2_Supporting
The NM_001321732.2(DDX41):c.-513G>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000133 in 1,591,986 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.000079 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00014 ( 0 hom. )
Consequence
DDX41
NM_001321732.2 5_prime_UTR_premature_start_codon_gain
NM_001321732.2 5_prime_UTR_premature_start_codon_gain
Scores
2
Splicing: ADA: 1.000
2
Clinical Significance
Conservation
PhyloP100: 3.22
Genes affected
DDX41 (HGNC:18674): (DEAD-box helicase 41) DEAD box proteins, characterized by the conserved motif Asp-Glu-Ala-Asp (DEAD), are putative RNA helicases. They are implicated in a number of cellular processes involving alteration of RNA secondary structure, such as translation initiation, nuclear and mitochondrial splicing, and ribosome and spliceosome assembly. Based on their distribution patterns, some members of the DEAD box protein family are believed to be involved in embryogenesis, spermatogenesis, and cellular growth and division. The protein encoded by this gene is a member of the DEAD box protein family and interacts with several spliceosomal proteins. In addition, the encoded protein may recognize the bacterial second messengers cyclic di-GMP and cyclic di-AMP, resulting in the induction of genes involved in the innate immune response. [provided by RefSeq, Jan 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -1 ACMG points.
BS2
High AC in GnomAd4 at 12 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DDX41 | NM_016222.4 | c.138+5G>T | splice_region_variant, intron_variant | ENST00000330503.12 | NP_057306.2 | |||
DDX41 | NM_001321732.2 | c.-513G>T | 5_prime_UTR_premature_start_codon_gain_variant | 2/16 | NP_001308661.1 | |||
DDX41 | NM_001321732.2 | c.-513G>T | 5_prime_UTR_variant | 2/16 | NP_001308661.1 | |||
DDX41 | NM_001321830.2 | c.-310+5G>T | splice_region_variant, intron_variant | NP_001308759.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DDX41 | ENST00000330503.12 | c.138+5G>T | splice_region_variant, intron_variant | 1 | NM_016222.4 | ENSP00000330349.8 |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152268Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
12
AN:
152268
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000136 AC: 29AN: 212810Hom.: 0 AF XY: 0.000129 AC XY: 15AN XY: 116404
GnomAD3 exomes
AF:
AC:
29
AN:
212810
Hom.:
AF XY:
AC XY:
15
AN XY:
116404
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000138 AC: 199AN: 1439718Hom.: 0 Cov.: 31 AF XY: 0.000144 AC XY: 103AN XY: 714692
GnomAD4 exome
AF:
AC:
199
AN:
1439718
Hom.:
Cov.:
31
AF XY:
AC XY:
103
AN XY:
714692
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152268Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74390
GnomAD4 genome
AF:
AC:
12
AN:
152268
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
74390
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
DDX41-related hematologic malignancy predisposition syndrome Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 30, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | St. Jude Molecular Pathology, St. Jude Children's Research Hospital | Mar 03, 2022 | The DDX41 c.138+5G>T intronic change results from a G to T substitution at the +5 position of intron 2 of the DDX41 gene. Algorithms that predict the impact of sequence changes on splicing indicate that this change may result in loss of the native donor at c.138 (PP3), but internal RNA data demonstrates normal splicing (BS3_supporting). This variant has a maximum subpopulation frequency of 0.026% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/variant/5-176943721-C-A). To our knowledge, this variant has not been reported in individuals with DDX41-related hematologic malignancy predisposition syndrome. In summary, this variant meets criteria to be classified as of uncertain significance based on the ACMG/AMP criteria: PP3, BS3_supporting. - |
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 13, 2024 | This sequence change falls in intron 2 of the DDX41 gene. It does not directly change the encoded amino acid sequence of the DDX41 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs187714514, gnomAD 0.03%), and has an allele count higher than expected for a pathogenic variant. This variant has been observed in individual(s) with DDX41-related conditions (PMID: 35671390, 37199125). ClinVar contains an entry for this variant (Variation ID: 434923). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 22, 2024 | In silico analysis indicates that this variant does not alter splicing; Observed in individuals with hematologic malignancies (PMID: 35671390, 37199125); This variant is associated with the following publications: (PMID: 35671390, 37199125) - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | May 26, 2017 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 23, 2024 | The c.138+5G>T intronic variant results from a G to T substitution 5 nucleotides after coding exon 2 in the DDX41 gene. This variant was reported in individual(s) with features consistent with DDX41-related hematologic malignancy conditions (Li P et al. Blood, 2022 Aug;140:716-755; Badar T et al. Haematologica, 2023 Nov;108:3033-3043). This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration may weaken the native splice donor site. Based on the available evidence, the clinical significance of this variant remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: 5
Find out detailed SpliceAI scores and Pangolin per-transcript scores at